xylometazoline: Clinical Trials

10 trials of xylometazoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 recruiting. 5 Not applicable, 3 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Recruiting 1, Unknown 1
Phase 43Completed 2, Unknown 1
Phase 31Completed 1

Follow xylometazoline: new trials by email Literature Review of xylometazoline trials Research Report on xylometazoline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxytocin's Effects on Emotional Processing and Its Acting Routes
placebo (compared to vasoconstrictor), vasoconstrictor (Otrivin), placebo (compared to oxytocin) - Healthy Adult Male
Not applicableRecruitingUniversity of Electronic Science and Technology of China1202026-01-242026-02-23
Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
Neomycin/ Dexameythasone/Xylometazoline, Bacillus subtilis DSM32444 - Rhinosinusitis, Rhinitis
Not applicableCompletedHuro Biotech Joint Stock Company602022-12-292024-03-05
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
0.9% NaCl physiological saline Nasal-spraying, LiveSpo Navax®, Augmentin 500Mg Tablet - Upper Respiratory Tract Infections
Not applicableCompletedAnabio R&D1752021-10-282024-08-22
Nasal Breathing and Physical Capacity
Otrivin - Nasal Obstruction, Copd
Phase 4UnknownSorlandet Hospital HF672021-01-132023-06-27
Xylometazoline During Nasal Flexible Bronchoscopy
Xylometazoline, Saline - Bronchoscopy
Not applicableCompletedAll India Institute of Medical Sciences1482018-06-012019-03-11
The Role of the Nose in Snoring and Sleep Apnea
Xylometazoline, placebo (saline) - Nasal Obstruction, Apnea, Obstructive Sleep
Not applicableUnknownLovisenberg Diakonale Hospital302017-03-012017-03-07
Nasal Prep for Nasendoscopy in Children
0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride, 0.05% xylometazoline hydrochloride, Isotonic normal saline - Flexible Nasendoscopy
Phase 4CompletedChildren's & Women's Health Centre of British Columbia692011-06-012012-12-06
Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold
Xylometazoline - Common Cold
Phase 3CompletedNovartis602007-03-012007-05-03
Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)
xylometazoline hydrochloride and ipratropium bromide (ZyComb) - Common Cold
CompletedNycomed10002006-12-012012-05-07
Nasal Decongestion and Obstructive Sleep Apnea
xylometazoline - Obstructive Sleep Apnea Syndrome, Rhinitis
Phase 4CompletedUniversity of Zurich122004-01-012009-12-23

Conditions studied

Common Cold (2)  ·  Nasal Obstruction (2)  ·  Rhinitis (2)  ·  Sleep Apnea, Obstructive (2)  ·  Otitis Media (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Tract Infections (1)  ·  Rhinitis, Allergic, Perennial (1)  ·  Rhinosinusitis (1)  ·  Sleep Apnea Syndromes (1)

Sponsors

All India Institute of Medical Sciences (1)  ·  Anabio R&D (1)  ·  Children's & Women's Health Centre of British Columbia (1)  ·  Huro Biotech Joint Stock Company (1)  ·  Lovisenberg Diakonale Hospital (1)  ·  Novartis (1)  ·  Nycomed (1)  ·  Sorlandet Hospital HF (1)  ·  University of Electronic Science and Technology of China (1)  ·  University of Zurich (1)

Countries

Norway (2)  ·  Vietnam (2)  ·  Canada (1)  ·  China (1)  ·  India (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Binh Nguyen Thanh, Assoc. Prof. (1)  ·  Karan Madan, MD, DM (1)  ·  Konrad E Bloch, MD (1)  ·  Shuxia Yao, Dr (1)  ·  Thanh Khieu Huu, MD.,PhD (1)

Results publications

PMID 18710420, PMID 19823201, PMID 24158493, PMID 32502854, PMID 33518471, PMID 36791622, PMID 39870748